Pharma and biotechnology companies regularly encounter conflicting interests and tensions. With leading legal expertise and a highly commercial approach to doing business in this dynamic sector we advise clients on a range of legal issues impacting their businesses.
Our team offers precise guidance in terms of corporate and M&A, competition, and tax structuring issues enabling our clients to succeed. We are experienced in all aspects of restructurings and public offerings in this field as well as competition law issues.
We advise Biotecha, Diamedica, Limedika, Gintarinė vaistinė, Pelion Healthcare Group.